IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice

E. C. Tsark, M. A. Dao, X. Wang, K. Weinberg, Jan Nolta

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The beige/nude/xid/human (bnx/hu) model of human hematopoiesis provides a unique opportunity to study extrathymic human T lymphocyte development in an in vivo system. Purified human hematopoietic stem cells develop into mature T lymphocytes and immature progenitors in the bone marrow of athymic bnx mice. The human T cells are all TCRαβ+ and display a restricted TCRVβ repertoire. In the current studies, we examined the effects of systemic human 1L-7 (huIL-7) administration on the phenotype and the activation status of the bnx/hu T cells. In the majority of the mice that did not have huIL-7 administration, a higher frequency of human CD3+/CD8+ than CD3+/CD4+ T cells developed in the bone marrow. This phenomenon is also frequently observed in human bone marrow transplant recipients. Extremely low levels of IL-2 were expressed by human CD3+ cells isolated from these mice, in response to PMA plus ionomycin and to CD3 and CD28 cross-linking. IL-4 was not expressed by cells exposed to either stimulus, demonstrating a profound inability of the bnx/hu T cells to produce this cytokine. Systemic production of huIL-7 from engineered stromal cells transplanted into the mice increased the human CD4 to CD8 ratios, and increased the ratio of memory to naive CD4+ and CD8+ T cells. The human CD3+ cells recovered from mice that had systemic huIL-7 and equivalent numbers of CD3+/CD4+ and CD3+/CD8+ cells in the marrow were still unable to produce IL-4 in response to any condition tested, but were capable of normal levels of IL-2 production following stimulation.

Original languageEnglish (US)
Pages (from-to)170-181
Number of pages12
JournalJournal of Immunology
Volume166
Issue number1
StatePublished - Jan 1 2001
Externally publishedYes

Fingerprint

Interleukin-7
Nude Mice
Bone Marrow
T-Lymphocytes
Interleukin-4
Interleukin-2
CD4-CD8 Ratio
Ionomycin
Hematopoiesis
Stromal Cells
Hematopoietic Stem Cells

ASJC Scopus subject areas

  • Immunology

Cite this

IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice. / Tsark, E. C.; Dao, M. A.; Wang, X.; Weinberg, K.; Nolta, Jan.

In: Journal of Immunology, Vol. 166, No. 1, 01.01.2001, p. 170-181.

Research output: Contribution to journalArticle

Tsark, E. C. ; Dao, M. A. ; Wang, X. ; Weinberg, K. ; Nolta, Jan. / IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice. In: Journal of Immunology. 2001 ; Vol. 166, No. 1. pp. 170-181.
@article{54f0fead4a744d6f94fed31f641863ba,
title = "IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice",
abstract = "The beige/nude/xid/human (bnx/hu) model of human hematopoiesis provides a unique opportunity to study extrathymic human T lymphocyte development in an in vivo system. Purified human hematopoietic stem cells develop into mature T lymphocytes and immature progenitors in the bone marrow of athymic bnx mice. The human T cells are all TCRαβ+ and display a restricted TCRVβ repertoire. In the current studies, we examined the effects of systemic human 1L-7 (huIL-7) administration on the phenotype and the activation status of the bnx/hu T cells. In the majority of the mice that did not have huIL-7 administration, a higher frequency of human CD3+/CD8+ than CD3+/CD4+ T cells developed in the bone marrow. This phenomenon is also frequently observed in human bone marrow transplant recipients. Extremely low levels of IL-2 were expressed by human CD3+ cells isolated from these mice, in response to PMA plus ionomycin and to CD3 and CD28 cross-linking. IL-4 was not expressed by cells exposed to either stimulus, demonstrating a profound inability of the bnx/hu T cells to produce this cytokine. Systemic production of huIL-7 from engineered stromal cells transplanted into the mice increased the human CD4 to CD8 ratios, and increased the ratio of memory to naive CD4+ and CD8+ T cells. The human CD3+ cells recovered from mice that had systemic huIL-7 and equivalent numbers of CD3+/CD4+ and CD3+/CD8+ cells in the marrow were still unable to produce IL-4 in response to any condition tested, but were capable of normal levels of IL-2 production following stimulation.",
author = "Tsark, {E. C.} and Dao, {M. A.} and X. Wang and K. Weinberg and Jan Nolta",
year = "2001",
month = "1",
day = "1",
language = "English (US)",
volume = "166",
pages = "170--181",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "1",

}

TY - JOUR

T1 - IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice

AU - Tsark, E. C.

AU - Dao, M. A.

AU - Wang, X.

AU - Weinberg, K.

AU - Nolta, Jan

PY - 2001/1/1

Y1 - 2001/1/1

N2 - The beige/nude/xid/human (bnx/hu) model of human hematopoiesis provides a unique opportunity to study extrathymic human T lymphocyte development in an in vivo system. Purified human hematopoietic stem cells develop into mature T lymphocytes and immature progenitors in the bone marrow of athymic bnx mice. The human T cells are all TCRαβ+ and display a restricted TCRVβ repertoire. In the current studies, we examined the effects of systemic human 1L-7 (huIL-7) administration on the phenotype and the activation status of the bnx/hu T cells. In the majority of the mice that did not have huIL-7 administration, a higher frequency of human CD3+/CD8+ than CD3+/CD4+ T cells developed in the bone marrow. This phenomenon is also frequently observed in human bone marrow transplant recipients. Extremely low levels of IL-2 were expressed by human CD3+ cells isolated from these mice, in response to PMA plus ionomycin and to CD3 and CD28 cross-linking. IL-4 was not expressed by cells exposed to either stimulus, demonstrating a profound inability of the bnx/hu T cells to produce this cytokine. Systemic production of huIL-7 from engineered stromal cells transplanted into the mice increased the human CD4 to CD8 ratios, and increased the ratio of memory to naive CD4+ and CD8+ T cells. The human CD3+ cells recovered from mice that had systemic huIL-7 and equivalent numbers of CD3+/CD4+ and CD3+/CD8+ cells in the marrow were still unable to produce IL-4 in response to any condition tested, but were capable of normal levels of IL-2 production following stimulation.

AB - The beige/nude/xid/human (bnx/hu) model of human hematopoiesis provides a unique opportunity to study extrathymic human T lymphocyte development in an in vivo system. Purified human hematopoietic stem cells develop into mature T lymphocytes and immature progenitors in the bone marrow of athymic bnx mice. The human T cells are all TCRαβ+ and display a restricted TCRVβ repertoire. In the current studies, we examined the effects of systemic human 1L-7 (huIL-7) administration on the phenotype and the activation status of the bnx/hu T cells. In the majority of the mice that did not have huIL-7 administration, a higher frequency of human CD3+/CD8+ than CD3+/CD4+ T cells developed in the bone marrow. This phenomenon is also frequently observed in human bone marrow transplant recipients. Extremely low levels of IL-2 were expressed by human CD3+ cells isolated from these mice, in response to PMA plus ionomycin and to CD3 and CD28 cross-linking. IL-4 was not expressed by cells exposed to either stimulus, demonstrating a profound inability of the bnx/hu T cells to produce this cytokine. Systemic production of huIL-7 from engineered stromal cells transplanted into the mice increased the human CD4 to CD8 ratios, and increased the ratio of memory to naive CD4+ and CD8+ T cells. The human CD3+ cells recovered from mice that had systemic huIL-7 and equivalent numbers of CD3+/CD4+ and CD3+/CD8+ cells in the marrow were still unable to produce IL-4 in response to any condition tested, but were capable of normal levels of IL-2 production following stimulation.

UR - http://www.scopus.com/inward/record.url?scp=0035172204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035172204&partnerID=8YFLogxK

M3 - Article

C2 - 11123290

AN - SCOPUS:0035172204

VL - 166

SP - 170

EP - 181

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 1

ER -